Secondary Structure of Huntingtin Amino-Terminal Region  by Kim, Mee Whi et al.
Structure
Article
Secondary Structure of Huntingtin
Amino-Terminal Region
Mee Whi Kim,1,* Yogarany Chelliah,2 Sang Woo Kim,2 Zbyszek Otwinowski,1 and Ilya Bezprozvanny3
1Department of Biochemistry
3Department of Physiology
2Howard Hughes Medical Institute
University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390, USA
*Correspondence: MeeWhi.Kim@UTSouthwestern.edu
DOI 10.1016/j.str.2009.08.002SUMMARY
Huntington’s disease is a genetic neurodegenerative
disorder resulting from polyglutamine (polyQ) expan-
sion (>36Q) within the first exon of Huntingtin (Htt)
protein. We applied X-ray crystallography to deter-
mine the secondary structure of the first exon (EX1)
of Htt17Q. The structure of Htt17Q-EX1 consists of
an amino-terminal a helix, poly17Q region, and poly-
proline helix formed by the proline-rich region. The
poly17Q region adopts multiple conformations in
the structure, including a helix, random coil, and
extended loop. The conformation of the poly17Q
region is influenced by the conformation of neigh-
boring protein regions, demonstrating the impor-
tance of the native protein context. We propose
that the conformational flexibility of the polyQ region
observed in our structure is a common characteristic
of many amyloidogenic proteins. We further propose
that the pathogenic polyQ expansion in the Htt pro-
tein increases the length of the random coil, which
promotes aggregation and facilitates abnormal inter-
actions with other proteins in cells.
INTRODUCTION
Huntington’s disease (HD) is an autosomal-dominant neu-
rodegenerative disorder. Neuropathological analysis of HD
patients reveals selective and progressive neuronal loss in the
striatum (Vonsattel and DiFiglia, 1998), particularly affecting the
GABAergic medium spiny striatal neurons (MSN). At the molec-
ular level, the cause of HD is a polyglutamine (polyQ) expansion
(R36Q) near the amino terminus of Huntingtin (Htt), a 350 kDa
ubiquitously expressed cytoplasmic protein (The Huntington’s
Disease Collaborative Research Group, 1993). The cellular
mechanisms that link Huntingtin polyQ expansion (Httexp) with
the disease are under intense investigation. Most evidence is
consistent with the hypothesis that polyQ-expanded Htt
acquires a ‘‘toxic gain of function’’ (Tobin and Signer, 2000). A
number of toxic functions have been assigned to Httexp,
including formation of toxic aggregates, effect on gene transcrip-
tion, induction of apoptosis, and disruption of key neuronal func-
tions such as proteosomal function, ubiquitination, axonal trans-
port, endocytosis, synaptic transmission, and Ca2+ signalingStructure 17, 1205–12(Bezprozvanny, 2009; Cha, 2007; Li and Li, 2004; Ross, 2002;
Rubinsztein, 2002; Tobin and Signer, 2000; Truant et al., 2008).
Many of the proposed mechanisms suggest that the mutant
Httexp is involved in pathological interactions with other signaling
proteins in cells, leading to neuronal dysfunction and death.
Information about the structure of the polyQ region of Htt is
critical for understanding Httexp toxicity, and might aid in the
development of potential HD therapies. However, the structure
determination of the polyQ region of Htt has proven to be an
extremely difficult problem (Temussi et al., 2003). In the aggre-
gated form, polyQ sequence most likely adopts b sheet structure
(Bevivino and Loll, 2001; Chen et al., 2001; Perutz, 1996; Perutz
et al., 2002; Singer and Dewji, 2006; Takahashi et al., 2008;
Tanaka et al., 2001). The biophysical studies of soluble mono-
meric form of polyQ fragments of various length provided
evidence for random coil conformation (Altschuler et al., 1997;
Bennett et al., 2002; Chen et al., 2001; Masino et al., 2002), for
a-helical conformation (Bhattacharyya et al., 2006; Nagai et al.,
2007), b sheet (Nagai et al., 2007), and extended helix (Chellgren
et al., 2006). Random coil, a and b sheet, a helix, m helix, and p
helix conformations have been predicted using computational
methods (Armen et al., 2005; Khare et al., 2005; Lathrop et al.,
1998; Tsukamoto et al., 2006; Wang et al., 2006). Recently the
crystal structure of the synthetic peptide GQ10G in the extended
conformation was determined in the complex with a monoclonal
antibody (Li et al., 2007). Although these studies provided impor-
tant insights into potential conformations of the polyQ sequence,
most of them have been performed in the absence of a native
protein context or yielded low-resolution data. Here we present
the secondary structure of the first exon (EX1) of Htt, containing
17 glutamines (Htt17Q) determined by X-ray crystallography at
atomic resolution. We discovered that the poly17Q region
adopts multiple conformations in the structure, including a helix,
random coil, and extended loop. We conclude that the confor-
mation of the poly17Q region is influenced by the conformation
of neighboring protein regions, demonstrating the importance
of the native protein context. We propose that the conforma-
tional flexibility of the polyQ region observed in our structure is
a common characteristic of many amyloidogenic proteins.
RESULTS
Crystallization of Htt17Q Exon 1 Fragment
The first exon of Huntingtin protein containing 17 glutamines
(Htt17Q-EX1) was expressed in bacteria and crystallized as12, September 9, 2009 ª2009 Elsevier Ltd All rights reserved 1205
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Secondary Structure of Huntingtin Exon1Figure 1. Secondary Structure of Htt17Q-EX1
(A) Amino acid sequence of MBP-Htt17Q-EX1. MBP3A denotes the maltose binding protein followed by a 3Ala linker. M371 to Q430 is the sequence of Htt17Q-
EX1, which is subdivided into a 17 aa N-terminal region (M371 to F387), poly17Q region (Q388 to Q404), poly11P region (P405 to P415), and 15 aa mixed P/Q
region (Q416 to Q430). The sequence from Q431 to the C terminus is the 19 aa tag added to facilitate crystallization.
(B) The structure of Htt17Q-EX1 trimer from c95 crystal. The structures of MBP and 3A linker are removed for clarity. The amino-terminal a helix of Htt17Q-EX1
extends from Met371 to Phe387 (Green). The following poly17Q region (orange) is a helical and unstructured (random coil). The poly11P region (blue) adopts a PP
helix (shown as stick model) in the kinked conformation. The initial part of the polyP/Q region (purple) is also in PP-helix conformation (shown as stick model). The
terminal part of the poly17Q region (orange) is in the extended conformation (shown as stick model).
(C) The structure of Htt17Q-EX1 trimer from cHg
99 crystal. Same as in (B) but the poly11P region is in the straight conformation.
(D) The complete structure of B molecule of Htt17Q-EX1 monomer from c95 crystal. The striped orange loops are for the random coil region between Gln389 and
Gln399, which is invisible on the map.
(E) The complete structure of A molecule of Htt17Q-EX1 monomer from cHg
99 crystal. The striped orange loops are for the random coil region between Gln391 and
Gln398, which is invisible on the map.maltose-binding protein (MBP) fusion protein (see Experimental
Procedures for details). The amino-terminal MBP molecule was
connected with Htt17Q-EX1 via a three-alanine (3A) linker. The
amino acid (aa) numbering in MBP-Htt17Q-EX1 construct
starts with MBP, so that Met1 in the Htt17Q corresponds to
Met371 in the MBP-Htt17Q-EX1. The sequence of Htt17Q-EX1
can be subdivided into several distinct regions (Figure 1A). The
N-terminal region of Htt17Q-EX1 starting at Met371 (Met1 in
Htt sequence) extends for 17 aa until Phe387. The next region
Gln388–Gln404 contains a stretch of 17Gln (poly17Q), which is
immediately followed by a stretch of 11Pro from Pro405 until
Pro415 (poly11P). The proline stretch is followed by 15 aa mixed
Pro and Gln region (polyP/Q) that spans from Gln416 to Gln430.
The native Htt sequence ends at Gln430 and is followed by 19 aa
C-terminal tag that was added to facilitate crystallization
(Figure 1A).1206 Structure 17, 1205–1212, September 9, 2009 ª2009 Elsevier LtX-ray diffraction data were collected for 30 crystals of MBP-
Htt17Q-EX1. The diffraction for all crystals was anisotropic, ex-
tending to 2.8 A˚ in the high-resolution directions [h, 0, 0] and
[0, k, 0] and 4.5 A˚ in the low-resolution direction [0, 0, l]. All crys-
tals were monoclinic, space group C121, with slightly different
unit cell size and b angles ranging from 90 to 99. The asym-
metric unit contained three molecules of MBP-Htt17Q-EX1
(designated as molecules A, B, C) in all crystals. The phasing
was done by molecular replacement (MR) using MBP structural
models (see Experimental Procedures for details). MR gave solu-
tions for seven crystals with complete maps for MBP and partial
maps for Htt17Q-EX1. The b angles and other crystallographic
parameters for these seven crystals are listed in Table 1.
Following MR, the models of Htt17Q-EX1 fragments in these
seven crystals were built separately but simultaneously. The final
refinement statistics for the seven crystals used in Htt17Q-EX1d All rights reserved
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Secondary Structure of Huntingtin Exon1Table 1. Diffraction Data Collection and Refinement Statistics for Seven Crystals Used for Htt17Q-EX1 Structure Determination
Crystal c90 ca
92 cb
92 c94
Data Collection
Wavelength (l) 1.55 0.98 0.98 1.55
Space group C121 C121 C121 C121
Unit cell parameter (A˚, )
a 162 163 163 160
b 101 101 101 100
c 142 138 137 140
b 90 92 92 94
Resolution limit (A˚) 3.8-41 / 3.8-4.1 4.0-37 / 4.0-4.6 3.5-37 / 3.5- 3.7 3.7–40 / 3.7-3.8
Rsym(%) 12.8 / 24.1 6.3 / 12.8 21.2 / 30.1 12.4 / 47.1
I/sI (overall/outer shell) 13.2 / 3.1 13.2 / 5.9 8.4 / 2.3 14.3 / 3.1
Redundancy (overall/outer shell) 2.0 / 1.9 1.8 / 1.7 3.2 / 2.8 2.4 / 1.7
Overall completeness (%) 64 92 69 83
Refinement
Overall mean B-factor (A˚2) 104 81 56 70
No. of data 16,075 21,188 18,671 19,565
Rwork / Rfree 0.251/0.303 0.245/ 0.292 0.247 / 0.295 0.272/0.298
RMS_D (A˚) 0.009 0.006 0.009 0.007
RMS_A () 1.180 0.937 1.149 1.171
PDB ID 3IO4 3IO6 3IOT 3IOU
Crystal c95 c99 cHg
99
Data Collection
Wavelength (l) 0.98 0.98 0.98
Space group C121 C121 C121
Unit cell parameter (A˚, )
a 163 163 101
b 100 101 162
c 137 134 139
b 95 99 99
Resolution limit (A˚) 3.5-37/3.5-3.6 3.5-43/3.5-3.6 3.5-40/3.5-3.7
Rsym(%) 9.9/33.2 8.6/35.0 16.0/24.8
I/sI (overall /outer shell) 9.7/2.9 10.0/1.3 15.0/4.8
Redundancy(overall/outer shell) 2.7/1.9 2.8/1.5 3.7/3.2
Overall completeness (%) 82 87 92
Refinement
Overall mean B-factor (A˚2) 56 82 48
No. of data 20472 20629 24515
Rwork / Rfree 0.257 / 0.267 0.263 / 0.280 0.243 / 0.280
RMS_D (A˚) 0.007 0.007 0.006
RMS_A () 1.335 0.979 0.961
PDB ID 3IOR 3IOV 3IOW
The crystals are sorted by b angle of unit cell (C121). The values of b angles are assigned to each crystal name in superscript. For the same b angles
crystals are noted by letters of the alphabet in subscript. The mercury socked crystal is indicated by Hg in subscript. PDB accession numbers for the
data collected with each crystal are shown in the last row.structure determination are summarized in Table 1. The Protein
Data Bank (PDB) accession numbers for each of the seven
data sets are also included in Table 1. The final seven structures
of Htt17Q-EX1 were very similar despite differences in b angles
in the corresponding crystals.Structure 17, 1205–12Secondary Structure of the Htt17Q-EX1 Fragment
MBP-Htt17Q-EX1 forms a trimer, composed of molecules A, B,
and C, and packed sandwich-like in the crystal (see Figure S1
available online). The trimer is likely to be an artifact of crystalli-
zation because MBP-Htt17Q-EX1 is a monomer in solution12, September 9, 2009 ª2009 Elsevier Ltd All rights reserved 1207
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Secondary Structure of Huntingtin Exon1Table 2. The Last Visible Residue in Poly17Q a Helix and Conformation of Poly11P in Different MBP-Htt17Q-EX1 Crystals
Crystal c90 ca
92 cb
92 c94 c95 c99 cHg
99
b angle 90 92 92 94 95 99 99
a helix A 395 388 388 388 388 390 389
a helix B 397 401 386 390 388 396 392
a helix C 395 396 391 400 396 393 402
PP helix Straight a Straight Kinked Kinked Kinked Straight
a Not resolved on the map.according to dynamic light scattering and size exclusion chro-
matography analysis (data not shown). Two representative
models of Htt17Q-EX1 trimer are shown in Figures 1B (crystal
c95) and 1C (crystal cHg
99). The models consist of the N-terminal
region of Htt17Q-EX1 starting with Met371 (green), the poly17Q
region (orange), and stretches of poly11P (blue) and a mixed
polyP/Q region (purple). The N-terminal region of Htt17Q-EX1
(green) is resolved as an a helix for all three molecules (A, B, C)
in the asymmetric unit. The structures of N-terminal a-helical
trimers are identical in all seven crystals and can be superim-
posed on each other. The initial portions of poly17Q region
(orange) on Figures 1B and 1C can be identified as an a helix
or loop for all three molecules. The rest of these poly17Q regions
are not visible on the map and not shown on Figures 1B and 1C.
Only a single poly11P region (blue) and an initial fragment of
polyP/Q region (purple) are resolved on the map in PP helix
form and the same region is invisible for other two molecules in
the asymmetric unit. The structure of poly11P in crystals c94,
c95, and c99 is kinked in the middle (Figure 1B, Table 2). In crys-
tals c90, cb
92, and cHg
99 the poly11P is straight (Figure 1C,
Table 2). In crystal ca
92 the poly11P region adopts a mixture of
‘‘kinked’’ and ‘‘straight’’ conformations and can not be clearly
resolved on the map (Table 2). The last 4 glutamine residues
from the poly17Q region immediately preceding poly11P reap-
pear on the map in the extended conformation (orange).
Examples of A and B molecules of Htt17Q-EX1 are shown on
Figures 1D and 1E. The B molecule from crystal c95 is shown
on Figure 1D. The structure of this molecule includes N-terminal
a-helix (green), polyQ stretch (orange), ‘‘kinked’’ poly11P region
(blue), and initial part of polyP/Q region (purple). The unstruc-
tured random coil portion of polyQ region (Gln389–Gln399) is
shown on Figure 1D as a striped orange loop. The remaining car-
boxy-terminal polyQ region (Gln400–Gln404) is resolved in the
extended loop conformation (orange stick model). The A mole-
cule from cHg
99 is shown on Figure 1E. This structure includes
N-terminal a helix (green), polyQ stretch (orange), straight
poly11P region (blue), and initial portion of the polyP/Q region
(purple). The beginning of the polyQ region (Gln388–Gln390) is
a helical and the carboxy-terminal portion of polyQ region
(Gln399–Gln404) is in the extended loop conformation (orange
stick model). The random coil portion of polyQ region in this
molecule (Gln391–Gln398) is shown by the striped orange loop.
Conformation of the Polyglutamine Region
For all three molecules (A, B, and C) in all seven crystals, the
N-terminal portion of Htt17Q-EX1 (green) is a helical (Figures 1B
and 1C). In all molecules, the N-terminal a helix continues until
Phe387 but eventually loses helical conformation within the1208 Structure 17, 1205–1212, September 9, 2009 ª2009 Elsevier LpolyQ region (orange). The remainder of polyQ region following
the a helices forms a ‘‘random coil’’ conformation. The polyQ
region is connected to the poly11P region in kinked (e.g.,
Figure 1D) or straight (e.g., Figure 1E) PP-helical conformations.
The last 4 Gln residues at the carboxy-terminal end of poly17Q
region (Gln400–Gln404) are in the extended conformation
(Figures 1D and 1E). The transition from a helix to a random
coil within poly17Q region occurs at variable positions for the
six molecules shown in Figure 1B and 1C. The examples of three
a helices with various lengths chosen from three different crys-
tals and corresponding electron density maps are presented
on Figure 2. The shortest helix is in the A molecule in crystal
c95. The a helix in this crystal continues only until Gln388, the first
residue of the poly17Q region, and then becomes a loop (Fig-
ure 2A). The diminishing electron density map of the polyQ
loop of the short a helix on Figure 2A approaches hydrophilic
residues Asp41, Lys42, Glu45, and Gln49 in MBP-B or MBP-A
molecules. The medium-length a helix is C molecule of crystal
c90, which extends until Gln395 and then becomes a loop (Fig-
ure 2B). The longest a helix is observed in the C molecule of
crystal cHg
99; it extends until Gln402 and then becomes random
coil that is invisible on the map (Figure 2C). Table 2 indicates the
last residues of the poly17Q a helixes for molecules A, B, and C in
each of the solved seven crystals with different b angles.
Conformation of the Polyproline Region
The poly11P region is resolved as PP helix in the crystals. Only
single poly11P helix is resolved in the trimer, which adopts
a kinked or straight conformation in different crystals (Table 2)
The beginning of poly11P in the kinked conformation is posi-
tioned at the equal distance between A and B N-terminal
a helices (Figure 1B), and the beginning of poly11P in the straight
conformation is positioned between A and C N-terminal a helices
(Figure 1C). The poly11P region is connected with the N-terminal
a helices via the polyQ random coil as described above.
Following poly11P region, a few residues from the polyQ/P
mixed region (shown in purple on Figures 1B and 1C) maintain
an extended conformation until the structure is no longer visible.
The parts of poly11P helix are stabilized by interactions with
hydrophobic surface of the a-helical trimers in the crystals
(Figures 1B and 1C).
DISCUSSION
The two parallel bar diagrams on Figure 3 show the protein
sequence of MBP-Htt17Q-EX1 and the corresponding sec-
ondary structure of each sequence region as determined from
our crystallographic data. The N-terminal region of Htt (M371td All rights reserved
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Secondary Structure of Huntingtin Exon1Figure 2. Structure of Amino-Terminal and Poly17Q Regions of Htt17Q-EX1
The structures of the amino-terminal region (green) and poly17Q region (orange) of Htt17Q-EX1 are shown for three different molecules with variable lengths of
poly17Q a helix. Also shown are corresponding regions of electron density maps contoured at 1.0 s (blue).
(A) The short poly17Q helix makes a transition to loop at Gln388 (molecule A, crystal c95).
(B) The medium poly17Q helix makes a transition to loop at Gln395 (molecule C, crystal c90).
(C) The long poly17Q helix extends for the length of the polyQ region until Gln402 (molecule C, crystal cHg
99).to F387) is a helical in all crystals (bold green). The N-terminal
a helix ends at variable residues within poly17Q region between
Q388 and Q400 (shaded green) and the rest of poly17Q region
continues as a random coil (not colored). The polyQ residues
immediately preceding poly11P region (Q400 to Q404) adopt
extended loop conformation (shaded blue). The poly11P region
exists as PP helix (bold blue) in all crystals, either in the kinked
or straight conformation. The secondary structure beyond
poly11P region continues as PP helix for several residues into
mixed P/Q region (shaded blue) until the structure can no longer
be resolved.
It is informative to compare our results with previous experi-
mental and modeling studies of Huntingtin and other polyQ-con-
taining proteins. The molecular dynamics simulations of Htt
amino-terminal headpiece predicted a-helical structure (KelleyStructure 17, 1205–12et al., 2009) and the a-helical structure of Htt amino-terminal
peptide was observed by circular dichroism (CD) spectra anal-
ysis (Atwal et al., 2007). However, predominantly random coil
conformation for the same region was reported by another group
based on CD and nuclear magnetic resonance spectra analysis
(Thakur et al., 2009). The Htt N-terminal headpiece modulates
subcellular localization and aggregation of Httexp (Atwal et al.,
2007; Rockabrand et al., 2007; Thakur et al., 2009), and definitive
information about its secondary structure is useful for under-
standing these effects. The N-terminal region of Htt is a helical
in all of our crystals (Figure 3), consistent with the molecular
dynamics simulations and biophysical measurements (Atwal
et al., 2007; Kelley et al., 2009). The agreement with these
studies indicates that ability to form an a helix is an intrinsic
property of the Htt amino-terminal region and not a result ofFigure 3. Schematic Diagram of the Secondary Structure Elements of Htt17Q-EX1
The first bar represents the sequence of MBP-Htt17Q-EX1 construct, which consists of MBP protein (not shown to scale), a three-alanine linker (3A), a 17-aa-long
N-terminal region of Htt (green), a polyQ region with 17 glutamine residues (poly17Q, orange), a polyP region with 11 proline residues (poly11P, blue), a 15-aa-long
mixed polyglutamine and polyproline region (polyP/Q, purple), and a C-terminal tag of 19 aa (not colored). The second bar is a summary of structural information
obtained from analysis of Htt17Q-EX1 structures resolved in the seven crystals. The main secondary structure elements of Htt17Q-EX1 are shown: a helix (bold
green), transition from a helix to random coil region (shaded green), random coil (uncolored), transition to extended loop region (shaded blue), PP helix (bold blue),
transition from PP helix to unstructured region (shaded blue).12, September 9, 2009 ª2009 Elsevier Ltd All rights reserved 1209
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Secondary Structure of Huntingtin Exon1crystallization of Htt17Q-EX1 as amino-terminal MBP-fusion
protein.
A range of structures was reported for polyQ region in previous
experimental and modeling studies. Some studies indicated
that monomeric polyQ peptide is unstructured and exists as
a random coil in solution (Altschuler et al., 1997; Bennett et al.,
2002; Chen et al., 2001; Masino et al., 2002). Using CD spectra
analysis, other groups concluded that polyQ stretch is at least
partially a helical (Bhattacharyya et al., 2006; Nagai et al.,
2007), an observation supported by modeling results (Lathrop
et al., 1998; Wang et al., 2006). We have found evidence for
both random coil and a-helical conformations of polyQ in our
structures (Figure 2), in agreement with both sets of observa-
tions. We further discovered that transition between a-helical
and random coil conformations of polyQ region occurs at
random positions (Figure 2, Table 2), indicating a very shallow
equilibrium between these two polyQ conformations as sug-
gested by molecular dynamics stimulations and biophysical
measurements (Bhattacharyya et al., 2006; Wang et al., 2006).
Additional biophysical and modeling studies provided evidence
that short polyQ stretches might also exist as the extended
conformation (Chellgren et al., 2006; Wang et al., 2006). The
ability of polyQ fragments to adopt an extended conformation
was further supported by crystal structure of GQ10G peptide
bound to a monoclonal antibody (Li et al., 2007). In our structures
the last 4 glutamine residues also adopt the extended conforma-
tion (Figure 3). The analysis of these structures led us to conclude
that the extended conformation at the carboxy-terminal end of
polyQ stretch is imposed by PP helix of the neighboring poly11P
region. Similar conclusions were reached in biophysical studies
of polyQ-polyP peptides in solution (Darnell et al., 2007). An
ability of poly11P region to stabilize the structure of a polyQ
stretch in the extended conformation might account for a known
role played by poly11P region in reducing aggregation and
toxicity of Httexp (Bhattacharyya et al., 2006; Darnell et al.,
2007; Dehay and Bertolotti, 2006; Duennwald et al., 2006).
The polyQ in the monomeric state is likely to exist in an equi-
librium among a-helical, random coil, and extended conforma-
tions, which is consistent with the range of structures observed
in Htt17Q-EX1 crystals (Figure 3) and with results obtained in
biophysical studies performed with the soluble proteins (Altsch-
uler et al., 1997; Bennett et al., 2002; Bhattacharyya et al., 2006;
Chellgren et al., 2006; Chen et al., 2001; Darnell et al., 2007;
Masino et al., 2002; Nagai et al., 2007). A similar conclusion
was reached in the recent conformational epitope mapping
study performed with the mutant Htt-EX1 fragment in solution
(Legleiter et al., 2009). The shallow equilibrium among a-helical,
loop, and extended conformations could be easily affected by
the length of polyQ sequence, neighboring protein context, inter-
actions with other proteins, changes in temperature, or ionic
composition. This ‘‘conformational flexibility’’ within Htt-polyQ
region observed in our structure might be a common character-
istic of many amyloidogenic proteins such as other polyQ-
disease proteins and proteins involved in Alzheimer disease,
Parkinson disease, and Prion disease (PrP) (Blondelle et al.,
1997; Fraser et al., 1991; Murphy, 2002; Nguyen et al., 1995; Te-
mussi et al., 2003). Similar to Htt-polyQ, the sequences of these
proteins also have been predicted to have an ambiguous
secondary structure and can easily adopt multiple conforma-1210 Structure 17, 1205–1212, September 9, 2009 ª2009 Elsevier Ltions, some of which might be toxic (Williams and Paulson,
2008).
The polyQ expansions of more than 36Q are toxic to cells and
cause HD and other neurodegenerative disorders (Gusella and
MacDonald, 2000). One explanation for the toxicity of polyQ
expansion is aggregation. The proteins containing expanded
polyQ repeats are prone to aggregation and some studies sug-
gested that polyQ aggregates are toxic to neurons (Ross,
2002; Truant et al., 2008). It is generally accepted that in the
aggregated state polyQ-expanded proteins adopt b sheet struc-
ture (Bevivino and Loll, 2001; Chen et al., 2001; Perutz, 1996;
Perutz et al., 2002; Singer and Dewji, 2006; Tanaka et al.,
2001). Some modeling and biophysical studies suggested that
monomeric polyQ can also adopt b sheet conformation in solu-
tion (Nagai et al., 2007; Wang et al., 2006). We have not observed
an evidence of b strand conformation in the Htt17Q-EX1 crystals
of wild-type Htt (Figure 3). However, it is possible that in the
mutant Httexp long polyQ random coil might adopt different
conformation, such as a b sheet (Nagai et al., 2007), whose
nucleation can occur from the random coil state of expanded
polyQ region (Uversky and Fink, 2004; Vitalis et al., 2008) or
from some other conformation that needs to be determined
experimentally. However, it has also been reported that patho-
genic and nonpathogenic monomeric polyQ tracts have similar
structural properties in solution (Klein et al., 2007), arguing
against major conformational changes in long polyQ tracks. To
address these questions, the crystal structure of Htt-EX1 con-
taining pathological polyQ expansion needs to be determined.
Another explanation for the pathogenic effects of polyQ
expansion is abnormal protein interactions. For example, toxicity
of Httexp might result from pathological interactions between
Httexp and signaling proteins in cells (Bezprozvanny, 2009;
Cha, 2007; Li and Li, 2004; Ross, 2002; Rubinsztein, 2002; Tobin
and Signer, 2000; Truant et al., 2008). From the structure we
found that the a-helical form of polyQ is not involved in any
strong molecular interactions. The random coil form of polyQ is
localized to the solvent area or near the polar residues of MBP,
suggesting weak interactions between polyQ random coil and
the polar residues of MBP. From these results we conclude
that the a-helical and random coil forms of Htt-polyQ region
are relatively ‘‘inert.’’ There are two potential mechanisms that
might account for interactions between expanded polyQ region
and other proteins. The first possibility is that the mutant polyQ
region adopts a novel conformation, which makes it more
‘‘sticky.’’ As discussed above, this ‘‘toxic’’ conformation can
be a b sheet or some other conformation. The second possibility
is that many weak protein interactions mediated by expanded
polyQ in the random coil conformation are sufficient to result in
pathological effects. In both cases the interactions between
expanded polyQ region (in novel toxic conformation or in random
coil conformations) would be stronger with certain amino acid
sequences in target proteins, resulting in some degree of spec-
ificity for these interactions.
In conclusion, we applied X-ray crystallography to determine
the secondary structure of the first exon of Huntingtin protein
containing 17Q sequence. The structure of Htt17Q-EX1 consists
of an amino-terminal a helix, a poly17Q region, and a PP helix
formed by the poly11P and mixed P/Q regions. The poly11P
region can adopt kinked or straight conformations. The poly17Qtd All rights reserved
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Secondary Structure of Huntingtin Exon1region displays ‘‘conformational flexibility’’ by adopting a-helical,
random coil, and extended loop conformations in our crystals.
The conformations of poly17Q region appear to be influenced
by the conformation of neighboring protein regions, demon-
strating the importance of the native protein context. We propose
that the conformational flexibility of the polyQ region observed in
our structure is a common characteristic of many amyloidogenic
proteins. We further propose that the pathogenic polyQ expan-
sion in the Httexp protein increases the length of the random
coil, which promotes Httexp aggregation and abnormal interac-
tions with other proteins in cells. Similar ideas are likely to be rele-
vant for understanding structure and toxicity of other polyQ-
containing proteins and amyloidogenic proteins in general.
EXPERIMENTAL PROCEDURES
Cloning, Protein Expression, Purification, Crystallization and X-ray
Diffraction Data Collection
The first exon (EX1) fragment of human Huntingtin containing 17 CAG repeats
(Met1-Gln60) was amplified by polymerase chain reaction and cloned into NotI
and PstI sites of the pMAL vector with modified 3Ala-linker (Center et al., 1998).
The aa numbering in the resulting MBP-Htt17Q-EX1 fusion protein is contin-
uous from the MBP protein, so that Met1 in Htt17Q sequence corresponds
to Met371 and Gln60 in Htt17Q sequence corresponds to Gln430. Following
Gln430 in the MBP-Htt17Q-EX1 sequence, the 19 aa carboxy-terminal
(C-terminal) tag (QSYQITAGKLGTGRRFTTS) was added to facilitate crystalli-
zation. MBP-Htt17Q-EX1 protein was expressed in BL21 bacteria and purified
on Maltose-binding affinity column, followed by molecular exclusion chroma-
tography (Superdex200, Pharmacia Biotech) using fast protein liquid chro-
matography. The purified MBP-Htt17Q-EX1 was crystallized in hanging drop
without removing MBP in order to improve protein solubility. Single crystals
300/300/20 mm in size grew in the mother drop containing 12% polyethylene
glycol, 200 mM Zn acetate, 200 mM sodium acetate, 100 mM sodium cacody-
late (pH 6.5–7.4) at 4C to 16C in 2 to 6 weeks. Synthetic 10Gaunadines RNA
was used as an additive in the molar ratio 1:1 to the protein during crystalliza-
tion. The crystals were frozen in mother liquid in liquid nitrogen and the X-ray
diffraction data were collected at the Advanced Photon Source 19ID beam
line. Some crystals were soaked in 1 mM CH3HgCl for 1 week prior to freezing.
The diffraction data collected from 30 crystals were indexed and processed by
HKL2000 (Minor et al., 2000).
Phasing by Molecular Replacement
All crystals of MBP-Htt17Q-EX1 had the monoclinic symmetry, space group
C121, with three molecules of MBP-Htt17Q-EX1 in the asymmetric unit
(ASU). For each crystal, phasing was done by MR using the Phaser program.
Forty MBP PDB files were downloaded from the Protein Data Bank and
different permutations of three MBP models were used as possible models
for three proteins in the ASU. The solutions for seven data sets produced by
MR were suitable to build a model of Htt17Q-EX1. The PDB files used in MR
for these seven crystals are shown in Table S1. The MBP structures described
in 1JW4, 1JW5, 10MP, 1LLS represent open forms without maltose and differ
primarily in the side-chain conformation. The crystals were nearly isomor-
phous but insufficient for averaging. Thus, the structure determination was
performed separately for each crystal. The electron density maps generated
by MR consisted of rich and poor electron density layers, with the gradual tran-
sition from rich to poor electron density (Figure S1). The rich electron density
layer corresponded to the layer of MBP molecules and the poor density layer
corresponded to the layer of Htt17Q-EX1 in the crystal. The model for Htt17Q-
EX1 was built using Coot. Table 1 summarizes the properties of the seven
crystals and corresponding diffraction data sets used in solving Htt17Q-EX1
structure.
Model Building and Refinement
When the seven maps generated by MR were compared, it became apparent
that the Htt17Q-EX1 fragments adopt somewhat different configuration in
different crystals. To account for this fact, the models of Htt17Q-EX1 frag-Structure 17, 1205–12ments in the seven crystals were built separately but simultaneously. Further-
more, to account for the weak diffraction from Htt17Q-EX1 fragment, the occu-
pancy of a corresponding model was chosen in the range between 0.80 and
0.30 to yield the best Rwork and Rfree factors during refinement using refmac5.
In the process of model building and refinement, the Rwork and Rfree were
improved and the electron density map of Htt17Q-EX1 became more clear.
Table 1 summarizes the final refinement statistics for the seven crystals
used for Htt17Q-EX1 structure determination.
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